Home›Companies›Biotech & Pharma›3Helix

3Helix, Inc.

Sells collagen-detecting peptides for laboratory research.

Updated Nov 9, 2026·Latest SEC filing Sep 21, 2026·Suggest an edit

About 3Helix

3Helix is a private company based in Salt Lake City, Utah, incorporated in 2023 in Delaware. It has reported $11,585,015 raised in two offerings on Form D since November 2023. Its chief executive is Michael Kirkness.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 31, 2026Sep 21, 2026$7,835,028of $10.0M target13$602KEquityRule 506(b)Form D ↗
Oct 26, 2023Nov 29, 2023$3,749,987of $6.0M target8$468KEquityRule 506(b)Form D ↗
Total, two offerings$11,585,015

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on 3Helix's Form D filed Sep 21, 2026.

NN
Noah Nasser
Director
Also a chief executive officer and director at Serimmune and datma.
NK
Nalini Kelly
Director
MF

Sources

  1. SEC3Helix, Inc. filing history
  2. CompanyAbout 3Helix